(HealthDay News) — Ambulatory, high-dose intravenous diuretic therapy seems to be cost saving for decompensated heart failure, according to a study published in The American Journal of Cardiology. Leo ...
Hypervolemia leads to disease progression and mortality in patients with heart failure. Intravenous diuretic therapy is the current standard of care for hypervolemic heart failure, but loop diuretics ...
The need to intensify oral diuretic therapy in patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) is significantly decreased with finerenone (Kerendia; ...
BURLINGTON, Mass., Feb. 9, 2026 /PRNewswire/ -- SQ Innovation, Inc. today announced that following its FDA approval in October 2025, Lasix® ONYU (furosemide injection) is now available for ordering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results